A 3-Year Follow-up Comparison of Clinical Outcomes from Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL)

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.4676-4677
Main Authors: Ghione, Paola, Palomba, Maria Lia, Ray, Markqayne D., Limbrick-Oldfield, Eve H., Owen, Jess, Kanters, Steve, Bobillo, Sabela, Ribeiro, Maria Teresa, Jacobson, Caron A., Neelapu, Sattva S., Ghesquieres, Herve, Nahas, Myrna, Beygi, Sara, Patel, Anik R., Gribben, John G.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-170469